Evidence map›Paper›PMID 25809979›Full record

ArticleJournal of clinical microbiology2015

Predominant Mycobacterium tuberculosis Families and High Rates of Recent Transmission among New Cases Are Not Associated with Primary Multidrug Resistance in Lima, Peru.

Francesca Barletta, Larissa Otero, Bouke C de Jong, Tomotada Iwamoto, Kentaro Arikawa, Patrick Van der Stuyft, Stefan Niemann, Matthias Merker, Cécile Uwizeye, Carlos Seas and 1 more

Abstract read
In one paragraph

Article in Journal of clinical microbiology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Dissecting rifampicin heteroresistance inJournal of medical microbiology · 2025
    Article
  5. Molecular epidemiology ofJournal of clinical tuberculosis and other mycobacterial diseases · 2024
    Review
  6. Article
  7. Article
  8. Article
  9. Circulation ofPathogens and global health · 2019
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Francesca BarlettaInstitute of Tropical Medicine Alexander von Humboldt, Cayetano Heredia University, Lima, Peru francescabarletta@yahoo.es.
Larissa OteroInstitute of Tropical Medicine Alexander von Humboldt, Cayetano Heredia University, Lima, Peru.
Bouke C de JongMRC Unit, Serekunda, The Gambia New York University, New York, New York, USA Mycobacteriology Unit, Institute of Tropical Medicine, Antwerp, Belgium.
Tomotada IwamotoKobe Institute of Health, Kobe, Japan.
Kentaro ArikawaKobe Institute of Health, Kobe, Japan.
Patrick Van der StuyftEpidemiology and Disease Control Section, Department of Public Health, Institute of Tropical Medicine, Antwerp, Belgium Ghent University, Ghent, Belgium.
Stefan NiemannMolecular Mycobacteriology, Research Center Borstel, Borstel, Germany German Center for Infection, Borstel Site, Borstel, Germany.
Matthias MerkerMolecular Mycobacteriology, Research Center Borstel, Borstel, Germany German Center for Infection, Borstel Site, Borstel, Germany.
Cécile UwizeyeMycobacteriology Unit, Institute of Tropical Medicine, Antwerp, Belgium.
Carlos SeasInstitute of Tropical Medicine Alexander von Humboldt, Cayetano Heredia University, Lima, Peru.
Leen RigoutsMycobacteriology Unit, Institute of Tropical Medicine, Antwerp, Belgium Antwerp University, Antwerp, Belgium.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sputum samples from new tuberculosis (TB) cases were collected over 2 years as part of a prospective study in the northeastern part of Lima, Peru. To measure the contribution of recent transmission to the high rates of multidrug resistance (MDR) in this area, Mycobacterium tuberculosis complex (MTBc) isolates were tested for drug susceptibility to first-line drugs and were genotyped by spoligotyping and 15-locus mycobacterial interspersed repetitive-unit (MIRU-15)-variable-number tandem repeat (VNTR) analysis. MDR was found in 6.8% of 844 isolates, of which 593 (70.3%) were identified as belonging to a known MTBc lineage, whereas 198 isolates (23.5%) could not be assigned to these lineages and 12 (1.4%) represented mixed infections. Lineage 4 accounted for 54.9% (n = 463) of the isolates, most of which belonged to the Haarlem family (n = 279). MIRU-15 analysis grouped 551/791 isolates (69.7%) in 102 clusters, with sizes ranging from 2 to 46 strains. The overall high clustering rate suggests a high level of recent transmission in this population, especially among younger patients (odds ratio [OR], 1.6; P = 0.01). Haarlem strains were more prone to cluster, compared to the other families taken together (OR, 2.0; P < 0.0001), while Beijing (OR, 0.6; P = 0.006) and LAM (OR, 0.7; P = 0.07) strains clustered less. Whereas streptomycin-resistant strains were more commonly found in clusters (OR, 1.8; P = 0.03), clustering rates did not differ between MDR and non-MDR strains (OR, 1.8; P = 0.1). Furthermore, only 16/51 MDR strains clustered with other MDR strains, suggesting that patients with primary MDR infections acquired the infections mostly from index cases outside the study population, such as retreated cases.

Indexed as

AdultAntitubercular AgentsDrug Resistance, MultipleFemaleHumansMaleMolecular EpidemiologyMycobacterium tuberculosisPeruProspective StudiesSputumTuberculosisYoung AdultAntitubercular Agents

Identifiers

PMID25809979
PMCPMC4432063

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.